Lonza Group AG | WebDisclosure

PRESS RELEASE

published on 10/22/2024 at 07:00, 1 year 3 months ago

Lonza Extends Collaboration with Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza extends collaboration with major pharmaceutical partner for integrated commercial supply of antibody-drug conjugates, including construction of dedicated bioconjugation capacity in Visp, and commercial antibody manufacturing for new ADC therapy

Lonza ADCs Commercial Supply Bioconjugation Pharmaceutical Partner
BRIEF

published on 10/03/2024 at 09:05, 1 year 3 months ago

Lonza Nominates David Meline as Independent Board Member

Board Of Directors Annual General Meeting Financial Experience Lonza Group David Meline
BRIEF

published on 10/03/2024 at 09:05, 1 year 3 months ago

Lonza nomme David Meline au poste de membre indépendant du conseil d'administration

Conseil D'administration Assemblée Générale Annuelle Expérience Financière Groupe Lonza David Meline
PRESS RELEASE

published on 10/03/2024 at 09:00, 1 year 3 months ago

Lonza Nominates David Meline as Independent Board Member
Lonza nominates David Meline, experienced CFO, for Board position. Olivier Verscheure not to seek re-election. Details on David's background and Lonza's activities

CFO Lonza Board Member David Meline Olivier Verscheure
BRIEF

published on 10/01/2024 at 16:50, 1 year 4 months ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville

Acquisition Pharmaceuticals Lonza Biologics Vacaville
BRIEF

published on 10/01/2024 at 16:50, 1 year 4 months ago

Lonza finalise l'acquisition d'un site de produits biologiques à grande échelle à Vacaville

Acquisition Lonza Médicaments Produits Biologiques Vacaville
PRESS RELEASE

published on 10/01/2024 at 16:45, 1 year 4 months ago

Lonza Completes Acquisition of Large-Scale Biologics Site in Vacaville (US) from Roche
Lonza completes acquisition of large-scale biologics site in Vacaville (US) from Roche, expanding US footprint and manufacturing capacity

Acquisition Manufacturing Lonza Roche Biologics
BRIEF

published on 09/24/2024 at 14:05, 1 year 4 months ago

Lonza and Vertex Sign Long-Term Supply Agreement for CASGEVY®

Lonza Cell Therapy Vertex CASGEVY® CRISPR/Cas9
BRIEF

published on 09/24/2024 at 14:05, 1 year 4 months ago

Lonza et Vertex signent un accord d'approvisionnement à long terme pour CASGEVY®

Lonza Sommet Thérapie Cellulaire CASGEVY® CRISPR/Cas9
PRESS RELEASE

published on 09/24/2024 at 14:00, 1 year 4 months ago

Lonza and Vertex Sign a Long-Term Commercial Supply Agreement for CASGEVY® (exagamglogene autotemcel)
Lonza and Vertex sign a long-term commercial supply agreement for CASGEVY® cell therapy based on CRISPR/Cas9 gene-editing technology. Lonza to manufacture at Geleen, NL facility approved by FDA, EMA, and MHRA

Lonza Cell Therapy Vertex CASGEVY® CRISPR/Cas9

Published on 02/02/2026 at 00:05, 1 hour 55 minutes ago

Resource Upgrade Drilling Begins on Challenger Open Pits
Published on 01/31/2026 at 03:15, 1 day 22 hours ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 23 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 2 days ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 2 days 2 hours ago

BE Resources Announces Private Placement

View all ACCESSWIRE

Published on 02/01/2026 at 20:25, 5 hours 35 minutes ago

WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 10 hours ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 13 hours ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 23 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 2 days 4 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call

View all EQS

Published on 01/30/2026 at 18:40, 2 days 7 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 2 days 7 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 2 days 8 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 8 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 17 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News